The bone sonometer market is experiencing growth due to the increasing prevalence of osteoporosis and other bone-related diseases, especially among the aging population. Bone sonometers are non-invasive diagnostic tools used to assess bone density, providing an alternative to traditional X-ray methods such as DEXA. These devices use ultrasound technology to measure bone strength and predict fracture risk, offering advantages such as portability, cost-effectiveness, and reduced radiation exposure. The market is driven by the growing demand for early diagnosis and prevention of osteoporosis, particularly in geriatric populations. Recent developments in the bone sonometer market include advancements in device portability, improved accuracy, and the integration of advanced technologies for better patient care. In addition, the expansion of healthcare infrastructure in emerging markets and increasing awareness about bone health are expected to further drive the growth of the bone sonometer market in the coming years.
